https://silviabolzani.journoportfolio.comRSS Feed for Silvia BolzanienThu, 04 Sep 2025 00:00:00 +0100https://media.journoportfolio.com/users/425097/images/f8afdc21-de5b-4393-ab12-e2fdad277ff6.pngA poster created for the Association of Italian Researchers in Japan, AIRJ, presented during their annual symposium.Thu, 04 Sep 2025 00:00:00 +0100https://media.journoportfolio.com/users/425097/images/f8afdc21-de5b-4393-ab12-e2fdad277ff6.pnghttps://media.journoportfolio.com/users/425097/images/0c57daf6-1ec8-4d00-b4b2-f39ad8a35fc5.pngA poster created for the Association of Italian Researchers in Japan, AIRJ, presented during their annual symposium.Thu, 04 Sep 2025 00:00:00 +0100https://media.journoportfolio.com/users/425097/images/0c57daf6-1ec8-4d00-b4b2-f39ad8a35fc5.pnghttps://media.journoportfolio.com/users/425097/uploads/6cce8e64-3f1e-457c-b303-bfbba2f60731.pdfAssessment of unmet needs in progressive multiple sclerosis, highlighting treatment gaps, limited options for non-active SPMS, and the urgency for innovative therapies, neurorepair strategies, and patient-centered care.Tue, 19 Aug 2025 00:00:00 +0100https://media.journoportfolio.com/users/425097/uploads/6cce8e64-3f1e-457c-b303-bfbba2f60731.pdfhttps://media.journoportfolio.com/users/425097/uploads/9b0affcf-2553-456e-a2f1-f2b1fa84fb40.pdfThis medical news article illustrates how natural killer (NK) cells, an important part of the immune system, could help in the development of new treatments for the novel coronavirus. It is aimed at an undergraduate audience.Thu, 05 Dec 2024 00:00:00 +0000https://media.journoportfolio.com/users/425097/uploads/9b0affcf-2553-456e-a2f1-f2b1fa84fb40.pdfhttps://media.journoportfolio.com/users/425097/uploads/b1ff8210-e102-4bf0-aa0d-893fbbc6e4ab.pdfThis structured overview is intended for physicians and presents a report from a meeting held by the Society for Women's Health Research. The focus is on endometriosis, with an emphasis on the obstacles to accurate and timely diagnosis, and an investigation of potential solutions for enhancing future outcomes.Wed, 04 Dec 2024 00:00:00 +0000https://media.journoportfolio.com/users/425097/uploads/b1ff8210-e102-4bf0-aa0d-893fbbc6e4ab.pdfhttps://pubmed.ncbi.nlm.nih.gov/?term=27367597%2C27138091%2C26084349%2C25916393%2C27699182%2C30689576%2C25477881&filter=years.2013-2024&sort=pubdatePublished manuscripts, focusing on immunology, virology, and their roles in autoimmune and neurological diseases.Wed, 04 Dec 2024 00:00:00 +0000https://pubmed.ncbi.nlm.nih.gov/?term=27367597%2C27138091%2C26084349%2C25916393%2C27699182%2C30689576%2C25477881&filter=years.2013-2024&sort=pubdatehttps://pubmed.ncbi.nlm.nih.gov/24883044/The tumor microenvironment and the protein expression changes in the in vitro co-culture system: insights into cancer biology and potential therapeutic strategies.Wed, 04 Dec 2024 00:00:00 +0000https://pubmed.ncbi.nlm.nih.gov/24883044/https://media.journoportfolio.com/users/425097/uploads/ba8dd93a-a5fd-4c12-8afe-a88340656421.pdfThis abstract summarizes an innovative study exploring the potential of CRISPR interference (CRISPRi) technology as a novel therapeutic approach for obesity. Designed for professionals in science and medicine, particularly those specializing in metabolic diseases, this overview provides insights into cutting-edge advancements in genetic intervention for metabolic health.Wed, 04 Dec 2024 00:00:00 +0000https://media.journoportfolio.com/users/425097/uploads/ba8dd93a-a5fd-4c12-8afe-a88340656421.pdf